ES410123A1 - Un metodo para suprimir la formacion de color en una formu-lacion farmaceutica que contiene salicilato. - Google Patents

Un metodo para suprimir la formacion de color en una formu-lacion farmaceutica que contiene salicilato.

Info

Publication number
ES410123A1
ES410123A1 ES410123A ES410123A ES410123A1 ES 410123 A1 ES410123 A1 ES 410123A1 ES 410123 A ES410123 A ES 410123A ES 410123 A ES410123 A ES 410123A ES 410123 A1 ES410123 A1 ES 410123A1
Authority
ES
Spain
Prior art keywords
choline salicylate
salicylate compounds
stabilized choline
stabilized
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES410123A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mundipharma AG
Original Assignee
Mundipharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma AG filed Critical Mundipharma AG
Publication of ES410123A1 publication Critical patent/ES410123A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES410123A 1971-07-26 1972-12-28 Un metodo para suprimir la formacion de color en una formu-lacion farmaceutica que contiene salicilato. Expired ES410123A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3494171A GB1397732A (en) 1971-07-26 1971-07-26 Stabilized choline salicylate compounds

Publications (1)

Publication Number Publication Date
ES410123A1 true ES410123A1 (es) 1976-05-16

Family

ID=10371855

Family Applications (2)

Application Number Title Priority Date Filing Date
ES402541A Expired ES402541A1 (es) 1971-07-26 1972-05-09 Un metodo para la preparacion de compuestos de salicilato de colina que contienen sulfito.
ES410123A Expired ES410123A1 (es) 1971-07-26 1972-12-28 Un metodo para suprimir la formacion de color en una formu-lacion farmaceutica que contiene salicilato.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES402541A Expired ES402541A1 (es) 1971-07-26 1972-05-09 Un metodo para la preparacion de compuestos de salicilato de colina que contienen sulfito.

Country Status (13)

Country Link
US (1) US3855282A (es)
AU (1) AU461584B2 (es)
CA (1) CA1009664A (es)
CH (1) CH590816A5 (es)
DE (1) DE2222902C2 (es)
DK (1) DK145540C (es)
ES (2) ES402541A1 (es)
FR (1) FR2147170B1 (es)
GB (1) GB1397732A (es)
IL (1) IL40542A (es)
IN (1) IN139346B (es)
NO (1) NO146137C (es)
ZA (1) ZA722798B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098813A (en) * 1971-07-24 1978-07-04 Mundipharma Ag Preparation of alkali metal choline salicylate salt complexes
EP0051962B1 (en) * 1980-11-05 1988-08-24 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
US5043168A (en) * 1990-04-26 1991-08-27 Sidmak Laboratories, Inc. Solid choline magnesium salicylate composition and method of preparing same
DE10227793A1 (de) * 2002-06-21 2004-01-08 Basf Ag Stabilisierte Cholinascorbat enthaltende Zusammensetzung
WO2006005692A1 (en) * 2004-07-09 2006-01-19 Akzo Nobel N.V. Composition comprising choline hydroxide and process for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1000902A (fr) * 1949-11-29 1952-02-18 Chimiotherapie Lab Franc Procédé amélioré pour la préparation des solutions aqueuses de sels d'acide paraaminosalicylique
DE1104118B (de) * 1959-05-15 1961-04-06 Benckiser Gmbh Joh A Verfahren zur Erhoehung der thermischen Stabilitaet von waessrigen, pharmakologisch wirksamen Aminozuckerderivatloesungen
US3069321A (en) * 1960-04-04 1962-12-18 Lab For Pharmaceutical Dev Inc Choline salicylate composition and methods of use
US3549370A (en) * 1966-11-23 1970-12-22 Hunt Chem Corp Philip A Quaternary ammonium bisulfites,sulfites or pyrosulfites as developer preservatives
DE1956626A1 (de) * 1969-11-11 1971-05-19 Basf Ag Verfahren zur Herstellung von Sulfitobetainen

Also Published As

Publication number Publication date
DE2222902C2 (de) 1985-06-13
NO146137B (no) 1982-04-26
IL40542A (en) 1979-07-25
DK145540C (da) 1983-05-02
IL40542A0 (en) 1972-12-29
DK145540B (da) 1982-12-06
US3855282A (en) 1974-12-17
CA1009664A (en) 1977-05-03
FR2147170A1 (es) 1973-03-09
NO146137C (no) 1982-08-04
ES402541A1 (es) 1975-04-01
AU461584B2 (en) 1975-05-29
CH590816A5 (es) 1977-08-31
ZA722798B (en) 1973-01-31
GB1397732A (en) 1975-06-18
DE2222902A1 (de) 1973-02-08
AU4232372A (en) 1973-11-22
IN139346B (es) 1976-06-12
FR2147170B1 (es) 1976-04-16

Similar Documents

Publication Publication Date Title
IL38678A0 (en) The manufacture of concentrated,liquid dyeing preparations of low salt content
GB1330878A (en) Ketamine resolution
CA966019A (en) Capsules containing water and aqueous solutions
GB1406621A (en) Derivatives of prostanoic acid
AU467578B2 (en) New cyclic urea derivatives and salts thereof process forthe production thereof and pharmaceutical preparations containing thesame
ES410123A1 (es) Un metodo para suprimir la formacion de color en una formu-lacion farmaceutica que contiene salicilato.
BE786456A (fr) Stabilisation de solutions aqueuses preparees a partir de methyl-silanes hydrolysables
GB1388178A (en) Benzylpyrimidine derivatives
AU465874B2 (en) Stable solutions of calcium salts
ES209721Y (es) Cadena de cierres de cremallera.
CA988930A (en) Derivatives of cysteine
AU470362B2 (en) Sulphinic acid derivatives
CA998613A (en) Aqueous shampoo comprising triethanolamine salt of a synthetic lipoprotein
GB1302202A (es)
CA881663A (en) Concentration of aqueous solutions
CA969739A (en) Method of preventing oxidation of alkali sulfite
GB1383292A (en) Process for preparing 1,3,4-thiadiazole-2-thiol compounds
GB1395929A (en) Thioureas
CS178874B2 (en) Method for production of copolymers constituted by vinylethers and polyenes
NL7416066A (nl) Trialkyl gesubstitueerde hydroxybenzylmalonaten en gestabiliseerde preparaten.
CA883703A (en) Stable concentrated aqueous solutions of basic oxazine dyestuffs
CA847426A (en) Aqueous coating solutions of polyamide-acids
CA833036A (en) Stabilized aqueous stannogluconic acid and preparation
CA970088A (en) Stable solutions of polyglutamic acid derivatives
CA999730A (en) Antioxidant for the aqueous solution of sulfite and/or bisulfite of sodium or potassium and process for preventing the oxidation of said aqueous solution